Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Wells

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Marine Pollution Bulletin|August 23, 2003
From mimeos to E-copy--a tribute to Professor R B (Bob) Clark, founding editor of the Marine Pollution BulletinPeter Wells, Jennifer Baker, Peter Chapman, et al.
The American Journal of Cardiology|August 25, 2004
Results of catheter ablation of typical atrial flutterHugh Calkins, Robert Canby, Raul Weiss, et al.
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|September 25, 2023
Introducing a Dynamic Reconstruction Methodology for Multilayered Structures in Atom Probe TomographyConstantinos Hatzoglou, Gérald Da Costa, Peter Wells, et al.
Nature|February 18, 2015
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformationTea Pemovska, Eric Johnson, Mika Kontro, et al.
Journal of Cardiovascular Electrophysiology|October 19, 2017
Intracardiac ablation for atrioventricular nodal reentry tachycardia using a 6 mm distal electrode cryoablation catheter: Prospective, multicenter, North American study (ICY-AVNRT STUDY)Peter Wells, Marc Dubuc, George J Klein, et al.
Experimental Eye Research|March 8, 2011
Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucomaGanesh Prasanna, Samantha Carreiro, Scott Anderson, et al.
Experimental Eye Research|May 19, 2009
Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical modelsGanesh Prasanna, Jay Fortner, Cathie Xiang, et al.
The Lancet. Respiratory Medicine|January 30, 2021
Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trialDean A Fennell, Amy King, Seid Mohammed, et al.
Eclinicalmedicine|June 16, 2022
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trialDean A Fennell, Catharine Porter, Jason Lester, et al.
Science (New York, N.Y.)|October 9, 2010
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonistsBeili Wu, Ellen Y T Chien, Clifford D Mol, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Marine Pollution Bulletin|August 23, 2003
From mimeos to E-copy--a tribute to Professor R B (Bob) Clark, founding editor of the Marine Pollution BulletinPeter Wells, Jennifer Baker, Peter Chapman, et al.
The American Journal of Cardiology|August 25, 2004
Results of catheter ablation of typical atrial flutterHugh Calkins, Robert Canby, Raul Weiss, et al.
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|September 25, 2023
Introducing a Dynamic Reconstruction Methodology for Multilayered Structures in Atom Probe TomographyConstantinos Hatzoglou, Gérald Da Costa, Peter Wells, et al.
Nature|February 18, 2015
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformationTea Pemovska, Eric Johnson, Mika Kontro, et al.
Journal of Cardiovascular Electrophysiology|October 19, 2017
Intracardiac ablation for atrioventricular nodal reentry tachycardia using a 6 mm distal electrode cryoablation catheter: Prospective, multicenter, North American study (ICY-AVNRT STUDY)Peter Wells, Marc Dubuc, George J Klein, et al.
Experimental Eye Research|March 8, 2011
Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucomaGanesh Prasanna, Samantha Carreiro, Scott Anderson, et al.
Experimental Eye Research|May 19, 2009
Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical modelsGanesh Prasanna, Jay Fortner, Cathie Xiang, et al.
The Lancet. Respiratory Medicine|January 30, 2021
Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trialDean A Fennell, Amy King, Seid Mohammed, et al.
Eclinicalmedicine|June 16, 2022
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trialDean A Fennell, Catharine Porter, Jason Lester, et al.
Science (New York, N.Y.)|October 9, 2010
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonistsBeili Wu, Ellen Y T Chien, Clifford D Mol, et al.
Pageof 4